Viking Therapeutics (NASDAQ: VKTX) Climbs 10% Following Results from Phase 1 Clinical Trial of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Hot FDA News Momentum Movers Trader Talk

Viking Therapeutic (VKTX) PT Raised to $125 at BTIGMarch 26, 2024 11:20 AM Viking Therapeutics (VKTX) Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of VK2735March 26, 2024 7:03 AM Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735March 26, 2024 7:03 AM